#cosmetics

10개의 글

September 28, 2026

Coreana Cosmetics (027050.KS) Stock Outlook 2026: A Veteran K-Beauty Brand Betting on ODM and Asset Value

Coreana Cosmetics (027050.KS) stock outlook for 2026. A close look at this Korean color-and-skincare cosmetics maker's dual brand-plus-ODM business model, how a K-beauty export recovery could feed its contract-manufacturing pipeline, its treasury-share and asset-value angle, domestic channel-shift risk from Olive Young and Daiso, and how a foreign investor would actually access, tax, and hedge a position in this KOSDAQ-listed name.

Coreana Cosmetics 027050 Korea Stocks

September 24, 2026

Kukje Pharma (KRX 002720) Stock Outlook 2026: A Legacy OTC and Eye-Care Maker's Consumer-Health Pivot

A qualitative 2026 stock outlook for Kukje Pharma (KRX 002720), a Korean generics and OTC pharmaceutical maker known for eye-care drops, that has diversified into face masks and cosmetics. We cover its pharmacy-channel moat, Korea's drug-price reset risk, peer comparisons against Yuhan, Daewoong and Hanmi, and how global investors should frame this small-cap KOSPI healthcare-consumer hybrid.

Kukje Pharma 002720 Korea Stocks

September 1, 2026

Korea Cosmetics Manufacturing (003350) Stock Outlook 2026: The Factory Behind K-Beauty, Not the Brand

A 2026 outlook on Korea Cosmetics Manufacturing (003350): why it is a cosmetics ODM and OEM manufacturer rather than a brand, how it differs from the separately listed seller Korea Cosmetics (123690), the reality of K-beauty export spillover, small-float volatility, peer comparison, and a practical playbook for investors.

Korea Cosmetics Manufacturing 003350 Korea Stocks

August 14, 2026

Pumtech Korea (251970) Stock Outlook 2026: Riding the K-Beauty Export Wave on Pumps and Airless Dispensers

Pumtech Korea (251970) 2026 stock outlook. A qualitative deep dive into its cosmetic pump, airless dispenser and packaging business, the K-beauty indie-brand export boom, dispensing know-how as a moat, and the real risks of customer concentration and beauty fashion cycles.

Pumtech Korea 251970 Korea Stocks

August 10, 2026

Tonymoly (214420) Stock Outlook 2026: A Road-Shop Brand Rebuilding on the K-Beauty Export Wave

Tonymoly (KRX 214420) 2026 stock analysis: the collapse of the single-brand road-shop model, the rebuild through Amazon and Costco in the US plus Japan and Southeast Asia, ODM and A2Gen probiotics diversification, K-beauty export tailwinds, and brand-aging turnaround risk.

Tonymoly 214420 Korea Stocks

August 1, 2026

Able CnC (KOSDAQ 078520) Stock Outlook 2026: MISSHA Rebrand Turnaround vs Road-Shop Decline

Able CnC (KOSDAQ 078520) 2026 stock outlook. A deep look at the MISSHA and A'PIEU brand rebrand, the shift from single-brand road shops to Olive Young health-and-beauty, online and Japan exports, structural road-shop decline, the IMM PE ownership overhang, valuation and margin volatility, benchmarked against Clio and Tonymoly.

Able CnC MISSHA A'PIEU

July 16, 2026

Amorepacific Group (002790) Stock Outlook 2026: The K-Beauty Reset vs the Holdco Discount

Amorepacific Group (KOSPI 002790) 2026 outlook for foreign investors. How the holding company differs from operating co 090430, the China and duty-free deleveraging, the US and Japan rebalancing, the Cosrx acquisition, Sulwhasoo and Laneige brand equity, and the NAV discount debate.

Amorepacific Group 002790 Korea Stocks

July 9, 2026

Aekyung Industrial (018250) Stock Outlook 2026: AGE 20's Beauty Rebound vs. Kerasys and 2080 Household Cash Cow

Aekyung Industrial (KOSPI: 018250) 2026 stock analysis for global investors: the AGE 20's cosmetics franchise reducing its China export dependence and rebranding, the Kerasys, 2080, and Trio household-goods cash cow, domestic consumption, raw-material and currency exposure, LINE Friends and IP collaborations, the beauty-segment rebound scenario, and Aekyung Group risk.

Aekyung Industrial 018250 Korea Stocks

July 8, 2026

CLIO Stock Outlook 2026: A K-Beauty Color Cosmetics Leader Between Channel Expansion and Trend Sensitivity

CLIO (KOSDAQ 237880) 2026 stock analysis: Peripera, Goodal, and CLIO brand portfolio, Olive Young H&B channel plus online and global (Japan, US Amazon) expansion, indie-brand competition, cost and marketing structure, and channel-dependence, China-exposure, and trend-sensitivity risks.

CLIO 237880 Korea Stocks

July 2, 2026

APR (278470) Stock Outlook 2026: Beauty-Tech Hypergrowth vs. a Steep Growth-Premium Valuation

APR Corp (KRX 278470) 2026 stock outlook. A qualitative deep dive into its beauty-tech model that fuses home beauty devices (Medicube AGE-R) with skincare brands, the razor-and-blade device-plus-consumables revenue engine, high-growth global expansion via Amazon and direct-to-consumer in the US and Japan, marketing-spend and trend-dependency risks, and the valuation compression danger baked into a growth premium.

278470 APR Corp Korea Stocks